ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1112

Hypereosinophilic Syndrome with Kidney and Bladder Involvement: A Case of Reduced GFR and Thickened Bladder Wall Responding to Low-Dosage Steroids

Session Information

  • Geriatric Nephrology
    November 08, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Geriatric Nephrology

  • 1300 Geriatric Nephrology

Authors

  • Bhatt, Anil Prasad, Renacare Center For Kidney Disease and Research, Noida, UP, India
  • Gupta, Bheem Raj, Sharda University, Greater Noida, UP, India

Group or Team Name

  • Renacare.
Introduction

Hypereosinophilic syndrome (HES) is defined by persistent eosinophilia (>1.5 billion /L) and organ involvement [1]. Renal manifestations are rare, occurring in 20% of cases, while bladder involvement is exceptional [2]. We report a case of HES with renal dysfunction, anemia, and bladder wall thickening in a patient with comorbidities, highlighting the need for tailored corticosteroid therapy in complex cases.

Case Description

A 74-year-old male with coronary artery disease (post-angioplasty) and bronchial asthma (12 years) presented with abdominal distension. Colonic biopsy showed eosinophilic colitis; skin biopsy confirmed leukocytoclastic vasculitis. Labs revealed eosinophilia (2.8 billion /L), creatinine 1.7 mg/dL (eGFR 32 mL/min/1.73 sq m, baseline 62 mL/min/1.73 sq m), hypoalbuminemia (2.01 g/dL), anemia, and ESR >100 mm/hr. CT showed a thickened bladder wall, suggesting eosinophilic cystitis. Kidney biopsy was deferred due to anticoagulation (clopidogrel). HES was diagnosed based on eosinophilia and multi-organ involvement. Methylprednisolone 32 mg daily caused bloating; 16 mg was intolerable, but 8 mg was effective, later reduced to 4 mg. This improved symptoms, normalized eosinophil count (1.2 billion /L), GFR (62 mL/min/1.73 sq m), creatinine (1.1 mg/dL), albumin (3.5 g/dL), anemia, and ESR.

Discussion

This case highlights HES with rare renal and bladder involvement. Reduced GFR (32 mL/min/1.73 sq m) and creatinine (1.7 mg/dL) suggest eosinophilic nephritis [2]. Bladder wall thickening indicates eosinophilic cystitis, a novel HES finding [3]. Anemia and ESR (>100 mm/hr) reflect systemic inflammation. High-dose methylprednisolone (32 mg) worsened gut symptoms, likely due to HES-related colitis [4]. Low-dose (4 mg) therapy normalized eosinophil count, GFR, creatinine (1.1 mg/dL), albumin, anemia, and ESR, showing a threshold effect [1]. Anticoagulation precluded kidney biopsy, emphasizing clinical diagnosis in HES. Individualized therapy is crucial in elderly patients with comorbidities like CAD and asthma, where corticosteroid intolerance complicates management.
References :
1. Klion AD. Annu Rev Med. 2009;60:293-306.
2. Dulohery MM. Kidney Int Rep. 2019;4(6):885-888.
3. Pineton de Chambrun G. Curr Opin Gastroenterol. 2011;27(6):533-539.
4. Ogbogu PU. J Allergy Clin Immunol. 2009;124(6):1319-1325.e3.

Digital Object Identifier (DOI)